NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-028-2018-1-JP-06 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS JP National Stage 2020-542580 Abandoned
NCI E-176-2014-0-SA-54 Anti-Human Papillomavirus 16 E7 T Cell Receptors SA DIV 520412601 Abandoned
NIAID E-198-2025-0-US-08 VIRAL SEROLOGY ASSAYS US 63/062,175 Expired
NHLBI E-036-2015-1-US-03 NK CELLS WITH AN INCREASED ANTIBODY-DEPENDENT CELLULAR TOXICITY (ADCC) AGAINST TUMORS US DIV 16/985,797 12188005 Issued PDF
NCI E-041-2018-0-US-04 A METHOD OF TREATING TRIPLE-NEGATIVE BREAST CANCER US National Stage 16/967,472 Pending
NCI E-068-2018-0-CA-07 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 CA National Stage 3090512 Pending
NCI E-080-2018-0-US-09 NANOPARTICLE-HYDROGEL COMPOSITE FOR NUCLEIC ACID MOLECULE DELIVERY US National Stage 16/967,302 11904057 Issued PDF
NIDDK E-028-2018-1-US-07 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS US National Stage 16/967,177 11584736 Issued PDF
NICHD E-185-2020-0-US-01 MULTIDIMENSIONAL MRI SIGNATURE FOR SPECIFIC DETECTION OF TRAUMATIC BRAIN INJURY IN VIVO US 63/061,105 Abandoned
NCATS E-027-2021-0-US-01 Quantum Dot Conjugated Virus Spike Protein For Cell-based Bio-sensing Systems And Drug Screening US 63/060,161 Abandoned
NICHD E-169-2020-0-US-01 Identification Of An Inverse Agonist For The Human GPR101 Orphan Receptor US 63/060,484 Abandoned
NCI E-190-2020-0-US-01 HLA CLASS I-RESTRICTED T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 63/060,340 Abandoned
NCI E-067-2017-0-HK-09 METHODS OF ISOLATING NEOANTIGEN-SPECIFIC T CELL RECEPTOR SEQUENCES HK EP 62020013025.5 Issued
NHLBI E-163-2019-0-PCT-02 Radiolabeled Sugars For Imaging Of Fungal Infections PCT PCT PCT/US2020/044446 Expired
NIA E-092-2011-0-US-12 USE OF (2R, 6R)-HYDROXYNORKETAMINE, (S)-DEHYDRONORKETAMINE AND OTHER STEREOISOMERIC DEHYDRO AND HYDROXYLATED METABOLITES OF (R,S)-KETAMINE IN THE TREATMENT OF DEPRESSION AND NEUROPATHIC PAIN US CON 16/945,163 Abandoned
NHLBI E-163-2019-0-EP-03 Radiolabeled Sugars For Imaging Of Fungal Infections EP National Stage 20757180.3 Pending
NCATS E-232-2020-0-US-01 MULTI-CYCLIC IRAK AND FLT3 INHIBITING COMPOUNDS AND USES THEREOF US 63/059,815 Abandoned
NIAID E-147-2015-0-ZA-15 BROADLY NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST HIV-1 V1V2 ENV REGION ZA DIV 2020/04763 Pending
NCI E-215-2017-0-US-07 STEREOSELECTIVE SYNTHESIS AND PROCESS FOR THE MANUFACTURING OF 2'-DEOXYNUCLEOSIDES US National Stage 16/966,398 11365211 Issued PDF
NCI E-196-2018-0-US-01 INSERT FOR PREPARING CELL CULTURE CHAMBERS US 63/058,794 Abandoned
NHGRI E-083-2020-0-US-01 DIAGNOSIS AND TREATMENT OF VEXAS, WITH MOSAIC MISSENSE MUTATIONS IN UBA1 US 63/059,107 Abandoned
NCI E-176-2014-0-JP-53 ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T-CELL RECEPTOR JP DIV 2020-127833 Issued
NINR E-134-2015-0-US-02 POINT OF NEED TESTING DEVICE AND METHODS OF USE THEREOF US DIV 16/941,333 12247250 Issued PDF
NIDDK E-028-2018-1-AU-02 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS AU National Stage 2019218256 Abandoned
NCI E-227-2017-0-DE-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		DE EP 18847175.9 Issued
NCI E-227-2017-0-FR-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		FR EP 18847175.9 Issued
NCI E-227-2017-0-GB-01 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		GB EP 18847175.9 Issued
NCI E-227-2017-0-EP-03 PURIFICATION AND LABELING OF EXTRACELLULAR VESICLES USING
A MIXED MODE RESIN COMPOSITION 		EP National Stage 18847175.9 Issued
NCI E-068-2018-0-US-06 TETHERED INTERLEUKIN-15 AND INTERLEUKIN-21 US National Stage 16/964,796 Pending
NIDDK E-144-2019-2-US-01 Treatment And Prevention Of Neuropathic Pain With P2Y14 Antagonists US ORD 16/936,951 11708346 Issued PDF
NINDS E-201-2020-0-US-01 NANOBODIES DIRECTED TO CORONAVIRUS SPIKE PROTEIN RECEPTOR
BINDING DOMAIN AND USES THEREOF 		US 63/055,865 Abandoned
NICHD E-170-2020-0-US-01 TIME EFFICIENT MULTI-PULSED FIELD GRADIENT (MPFG) MRI WITHOUT CONCOMITANT GRADIENT FIELD ARTIFACTS US 63/055,150 Abandoned
NIAID E-064-2015-3-US-01 MYELIN OLIGODENDROCYTE GLYCOPROTEIN, MYELIN BASIC PROTEIN, AND PROTEOLIPID PROTEIN COMPOSITIONS AND METHODS OF USE US CIP 16/934,573 12458683 Issued PDF
NIAID E-033-2018-0-US-06 BROADLY PROTECTIVE INACTIVATED INFLUENZA VIRUS VACCINE US National Stage 16/963,718 11369675 Issued PDF
NHLBI E-191-2020-0-US-01 SYSTEMS AND METHODS FOR MITRAL VALVE REPLACEMENT US 63/054,623 Abandoned
NIDDK E-028-2018-1-EP-05 HETEROCYCLIC P2Y14 RECEPTOR ANTAGONISTS EP National Stage 19707559.1 Pending
NCI E-181-2019-0-CN-01 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains CN National Stage 202080052372.2 Issued
NCI E-021-2015-0-HK-30 Anti-CD70 Chimeric Antigen Receptors HK EP 42020011615.0 Issued
NCI E-181-2019-0-PCT-02 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains PCT PCT PCT/US2020/042469 Expired
NCI E-181-2019-0-US-05 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains US National Stage 17/597,580 Pending
NIA E-214-2018-0-US-04 PHENOTYPIC AGE AND DNA METHYLATION BASED BIOMARKERS FOR LIFE EXPECTANCY AND MORBIDITY US National Stage 16/963,065 Pending
NCI E-181-2019-0-EP-03 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains EP National Stage 20751027.2 Pending
NCI E-181-2019-0-JP-04 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains JP National Stage 2022-503413 Pending
NCI E-181-2019-0-MO-01 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains MO CN J/009659 Pending
NCI E-181-2019-0-CN-03 Chimeric Antigen Receptors Containing Glypican 2 Binding Domains CN DIV 202510522686.9 Pending
NEI E-212-2015-0-US-08 METHOD FOR REPRODUCIBLE DIFFERENTIATION OF CLINICAL-GRADE RETINAL PIGMENT EPITHELIUM CELLS US CON 16/931,003 12065671 Issued PDF
NHGRI E-212-2020-0-US-02 System And Method For Estimating A Quantity Of Interest Based On An Image Of A Histological Section US ORD 16/251,730 11776115 Issued PDF
NHGRI E-212-2020-2-US-01 System And Method For Estimating A Quantity Of Interest Based On An Image Of A Histological Section US CIP 16/930,602 Abandoned
NCI E-172-2020-0-US-01 HLA CLASS II-RESTRICTED DRB T CELL RECEPTORS AGAINST RAS WITH G12V MUTATION US 63/052,502 Abandoned
NHLBI E-127-2020-0-US-01 METHODS TO PRODUCE VERY LONG CHAIN FATTY ACIDS US 63/051,520 Abandoned